Kavar Capital Partners Group LLC cut its holdings in GSK plc ( NYSE:GSK – Get Rating ) by 9.4% during the 4th quarter, according to its most recent disclosure with the SEC. The institutional investor owned 54,825 shares of the pharmaceutical company's stock after selling 5,685 shares during the period. Kavar Capital Partners Group LLC's holdings in GSK were worth $1,927,000 as of its most recent filing with the SEC. Several other institutional investors and hedge funds have also modified their holdings of GSK.

https://www.dailypolitical.com/2023/05/26/kavar-capital-partners-group-llc-has-1-93-million-holdings-in-gsk-plc-nysegsk.html

#dailypolitical